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Background: Acute pancreatitis (AP) is a common inflammatory disease of the pancreas accompanied by serious
metabolic disturbances. Nevertheless, the specific metabolic process of this disease is still unclear. Characterization
of the metabolome may help identify biomarkers for AP. To identify potential biomarkers, this study therefore
investigated the 1H-nuclear magnetic resonance (NMR)-based metabolomic profile of AP.
Methods: Fourteen male adult Sprague–Dawley rats were randomized into two groups: the AP group, in which AP
was induced by retrograde ductal infusion of 3.5% sodium taurocholate; and the sham operation group (SO), in
which rats were infused with 0.9% saline. Blood samples were obtained 12 hours later and a 600 MHz
superconducting NMR spectrometer was used to detect plasma metabolites. Principal components analysis (PCA)
and partial least squares-discriminant analysis after orthogonal signal correction (OSC-PLS-DA) were used to analyze
both longitudinal Eddy-delay (LED) and Carr–Purcell–Meiboom–Gill (CPMG) spectra.
Results: Differences in plasma metabolites between the two groups were detected by PCA and PLS-DA of 1HNMR
spectra. Compared with the SO group, plasma levels of lactate (δ 1.3, 1.34, 4.1), valine (δ 0.98, 1.02), succinic acid
(δ 2.38), 3-hydroxybutyric acid (3-HB, δ 1.18), high density lipoprotein (HDL, δ 0.8), and unsaturated fatty acid (UFA,
δ 2.78, 5.3) were elevated in the AP group, while levels of glycerol (δ 3.58, 3.66), choline (δ 3.22), trimethylamine
oxide (TMAO, δ 3.26), glucose (δ 3–4), glycine (δ 3.54), very low density lipoprotein (VLDL, δ 1.34) and
phosphatidylcholine (Ptd, δ 2.78) were decreased.
Conclusions: AP has a characteristic metabolic profile. Lactate, valine, succinic acid, 3-HB, HDL, UFA, glycerol,
choline, TMAO, glucose, glycine, VLDL, and Ptd may be potential biomarkers of early stage AP.
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Acute pancreatitis (AP) is a common inflammatory dis-
ease of the pancreas caused by premature activation of
pancreatic enzymes. Although AP is self-limiting in 80%
of patients, it can be life-threatening in the 20% who
develop systemic complications, such as multiple organ
failure [1]. In addition to a high mortality rate, ranging
from 3–15% [2], the rate of hospitalization for AP con-
tinues to rise annually [3]. In the United States, the overall
hospitalization rate has doubled over the past 20 years [4],
and in the Netherlands there was a 75% increase from* Correspondence: wftang900@gmail.com
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unless otherwise stated.1992 to 2004 [5]. A recent study suggested a 3.1% annual
increase in the incidence of AP [6] in England, and a
meta-analysis from 18 European countries showed that
the incidence of biliary pancreatitis has increased linearly
and that the mortality rate increases with age [7]. Similar
findings were reported in a study investigating the epi-
demiology of AP in the North Adriatic region of Croatia
[8]. A population-based study from Taiwan reported that
the proportion of severe cases has increased in recent
years, although the overall incidence of AP remained
constant [9]. Moreover, throughout the world, AP poses a
heavy financial burden on the health care system. Due to
unclear pathogenesis, the main treatments of AP are still
supportive and symptomatic therapies, although early
diagnosis and intervention may mitigate illness and reducehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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bolic disturbances, such as hyperglycemia and hyperlipid-
emia, are always present in the early stages of AP.
However, the specific metabolic processes associated with
this disease remain unclear.
Metabolomics is a modern approach to the study of
biological samples, and can provide detailed information
on the metabolic changes taking place in an organism in
various pathophysiologic states. 1H NMR spectroscopy-
based approaches are used for high-throughput research
on biological samples [14-16]. Moreover, being non-
invasive and providing an impartial profile of all metab-
olites, 1H NMR-based metabolomics is widely applied in
many areas related to biology and medicine, such as the
exploitation of new drugs, disease diagnosis, toxicology,
pharmaceutical effects, microorganism metabolomics,
and identification of biomarkers [17-21]. Detection of
characteristic metabolite changes in AP may increase
our understanding of the pathophysiology of this dis-
ease, allow early diagnosis, and identify potential thera-
peutic targets. To identify potential biomarkers of AP,
we analyzed the metabolic differences between rats with
AP and healthy rats.Methods
Ethics statement
This prospective, randomized controlled trial was per-
formed at the ethnopharmacology laboratory of West
China Hospital. The study protocol was approved by the
Ethics Committee for Animal Experiments of Sichuan
University. All rats were handled according to University
Guidelines and the Animal Care Committee Guidelines
of West China Hospital. All operations were performed
under chloral hydrate anesthesia, and all efforts were
made to minimize suffering.Chemicals
Deuterium oxide (D2O, 99.9%) was purchased from
Cambridge Isotope Laboratories, Inc (Tewksbury, MA,
USA). Trimethylsilyl-propionate-2, 2, 3, 3-d4 acid, so-
dium salt (TSP) was purchased from Merck (Darmstadt,
Germany). Sodium taurocholate was provided by Sigma
Chemical (St. Louis, MO, USA). Chloral hydrate was
provided by Ke Long chemical reagent works, China.Equipment
An INOVA 600 MHz NMR spectrometer equipped with a
triple-resonance probe and a z-axis pulsed field gradient
was obtained from Varian Unity (Varian, Inc. USA), a
microcentrifuge from Eppendorf MiniSpin Plus, Germany,
and a two-channel micro-injection pump from Kd Scien-
tific Company, USA.Animal model of acute pancreatitis
Healthy male adult Sprague–Dawley rats (224 ± 21 g, 200–
250 g b/w), were maintained in air-conditioned animal
quarters at 22 ± 2°C with a relative humidity of 65% ± 10%.
They were acclimated for 1 week before the experiment
with special feed and tap water. The animal experiments
were carried out in the Laboratory of Ethnopharmacology
at West China hospital, Sichuan University.
Fourteen 2-month-old (55–62 days old) rats obtained
from the experimental animal center of Sichuan Univer-
sity were numbered and randomized into two groups of
seven rats each, an AP group and a sham operation (SO)
group. Animals were fasted for 12 h, and given free ac-
cess to tap water prior to experiments. All animals were
anesthetized by intraperitoneal injection of 3 ml/kg 10%
chloral hydrate. The hepatic duct was closed with a small
bulldog clamp, and the biliopancreatic duct was cannulated
through the offside of the front opening of the duodenum
papilla. Rats in the AP group underwent retrograde pan-
creaticobiliary duct injection with 1 ml/kg 3.5% sodium
taurocholate using an infusion pump, whereas rats in the
SO group were similarly injected with 1 ml/kg 0.9% saline
[22]. Twelve hours later, heparinized blood samples were
obtained from the angular vein and centrifuged for 15 mi-
nutes at 3000 rpm. Plasma samples were collected and
stored at −80°C until use. After the experiment, the rats
were sacrificed and cremated.
Sample preparation and NMR data acquisition
Plasma samples (150 μl) were mixed with 100 μl 1 mg/
ml TSP in deuterium oxide D2O and 350 μl D2O, and
centrifuged at 14000 rpm for 10 min. A 550 μl aliquot of
supernatant was transferred into 5 mm NMR tubes, and
NMR spectra were recorded at 26°C using an INOVA
600 MHz NMR spectrometer equipped with a triple-
resonance probe and a z-axis pulsed field gradient. Infor-
mation about micromolecular metabolites was acquired
using a CPMG pulse sequence [−RD–90°–(r–180°–r)n–
ACQ] during a relaxation delay of 2 s. Sixty-four free in-
duction decays (FID) were collected into 64 k data points
with a spectral width of 8000 Hz and acquisition time of
4 s. Information about macromolecular metabolites was
collected by LED pulse sequence (−RD-90°-G1-180°-G1-
90°-T-90°-G1-180°-G1-90°-ACQ) during a relaxation delay
of 2 s. Sixty-four FID were collected into 64 k data points
with a spectral width of 8000 Hz, an acquisition time of
4 s and a diffusion time of 100 min. FID was zero-filled
and multiplied by an exponential line-broadening func-
tion of 1 Hz (for CPMG) and 3 Hz (for LED) prior to
Fourier transformation.
NMR data processing and analysis
After Fourier transformation, the data were phased and
subjected to baseline correction. For CPMG data, spectra
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regions of 0.04 PPM width. LED data were subdivided into
integrated regions of 0.04 PPM width corresponding to
the region of δ 0–6.0, and the spectra in the δ 4.6–5.0
range were excluded from data reduction. Each data point
was normalized to the sum of its row to compensate for
any variation in total sample volumes. The obtained data
were exported to Excel and subjected to multivariate
analyses as variables for the multivariate pattern recogni-
tion analysis using Soft Independent Modeling of Class
Analogy (SIMCA-P) software package (v10.04, Umetrics,
Umeå, Sweden). Principal components analysis (PCA) was
performed after data were pretreated by mean centering
and Pareto scaling. For samples with obvious internal indi-
vidual differences, partial least squares (PLS) and discrim-
inant analysis (DA) were conducted after data processing
based on orthogonal signal correction (OSC). These two
approaches were performed to differentiate between sam-
ple groups. Score plots were used to visualize the separ-
ation of the groups, while the loading plots were used to
determine which spectral variables significantly contrib-
uted to the separation of the samples on the score plots.Results
1H-NMR spectra (CPMG) and pattern recognition analysis
of plasma samples
A comparison of the 1H-NMR spectra of plasma samples
taken from rats in the AP and SO groups showed obvious
differences in the levels of small molecule metabolites
(Figure 1). To identify these differences in metabolic pro-
files, the 1H-NMR spectra were segmented and subjected
to PCA. The scores plot showed a cluster distribution of
the two groups without distinct separation, with the point
AP10 located outside the confidence interval (Figure 2a).
The clusters became more obviously distributed after
excluding the AP10 point (Figure 2b). With the loadingFigure 1 Plasma 1H-NMR spectrogram of CPMG. Sham operation groupplot (Figure 2d), a sequence of metabolic alterations was
detected in plasma samples from rats with AP: (1) in-
creased levels of lactate, valine, succinic acid, and 3-
hydroxybutyric acid (3-HB); and (2) decreased levels of
glycerol, choline, trimethylamine oxide (TMAO), glucose,
and glycine (Table 1). These altered metabolites may be
potential biomarkers of AP.
1H-NMR spectra (LED) and pattern recognition analysis of
plasma samples
Similar to the analysis of small molecule metabolites,
the levels of macromolecule lipid metabolites differed
markedly between the AP and SO groups, as shown by
the 1H-NMR (LED) spectra of their plasma samples
(Figure 3). To illustrate the differences in metabolic pro-
files required OSC-PLS (ctr) analysis (Figure 4a,b) was
conducted because PCA analysis was not able to detect
differences between these two groups (Figure 4c,d). The
score plot showed distinct separation between the two
groups (Figure 4a), with the loading plot (Figure 4b)
showing increases in high density lipoproteins (HDL,
0.86) and unsaturated fatty acids (UFA, 2.78, 5.3), and
decreases in very low density lipoprotein [(VLDL, 1.34),
(VLDL/LDL, 1.3)] and phosphatidylcholine (Ptd, 2.78)
(Table 2). Therefore, HDL, UFA, VLDL, and Ptd may be
potential biomarkers of AP.
Discussion
By analyzing the plasma metabolites of rats with experi-
mental AP using the 1H-NMR-based metabolomic ap-
proach, we obtained a series of finger-prints containing
information on plasma metabolites. Except for one point,
the separation between the two groups was distinct, as
shown in the score plot of PCA models of the CPMG data
for small molecules. Similarly, we observed a separation of
metabolites between the two groups in the score plot of(SO) and acute pancreatitis group (AP).
Table 1 Levels of small molecule metabolites in the AP
and SO groups









3 ~ 4 Glucose ↓
3.54 Glycine ↓
↑: elevated; ↓: reduced; 3-HB: 3-hydroxybutyric acid; TMAO: trimethylamine
oxide. All of the results were compared with sham operation (SO) group.
Figure 2 1H-NMR (CPMG) spectra of plasma samples. Samples from SO (red square symbol) and AP (●) groups. (a) Score plot of PCA analysis
shows cluster distribution of the two groups but without distinct separation, with the point y10 located outside the confidence interval. (b) Score
plot of PCA analysis after excluding the AP10 point. (c) Loading plot of PCA analysis. (d) Loading plot of PCA analysis after excluding the AP10
point. R2X (cum) =84.9%; Q2 (cum) =75.9%.
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groups were mixed by PCA.
The plasma 1H-NMR spectra of CPMG data for small
molecules showed a difference between the two groups.
The score plot with PCA of 1H-NMR (CPMG) spectra
of plasma samples showed that most of the metabolites
in the AP group could be separated from those in the
SO group, indicating a significant difference in metabo-
lomics between AP and control rats. The score plot with
PCA of 1H-NMR (LED) spectra from the two groups
showed a cross distribution. The cluster distribution of
the PLS-DA could distinguish between the two groups,
thus illustrating their metabolomic differences.
This study also showed differences in plasma meta-
bolite levels between the two groups. Rats with AP
had higher levels of lactate, valine, succinic acid, 3-
hydroxybutyrate (3-HB), HDL, and UFA, and lower
levels of glycerol, choline, TMAO, glucose, glycine,
VLDL, and phosphatidylcholine, than the control group.
Figure 4 1H-NMR (LED) spectra of plasma samples. Samples from SO (red square symbol) and AP (●) groups. (a) Score plot of OSC-PLS-DA.
(b) Loading plot of OSC-PLS-DA. R2X (cum) = 70.2%; R2Y (cum) = 87.1%; Q2 (cum) = 72.4%. (c) Score plot of PCA analysis. (d) Loading plot of
PCA analysis.
Figure 3 Plasma 1H-NMR spectrogram of LED. Sham operation group (SO) and acute pancreatitis group (AP).
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Table 2 Levels of macromolecular lipid metabolites in the
AP and SO groups










↑: elevated; ↓: reduced; −: similar; HDL: high density lipoprotein; LDL: low
density lipoprotein; VLDL: very low density lipoprotein; FA: saturated fatty acid;
Ptd: phosphatidylcholine; UFA: unsaturated fatty acid. All of the results were
compared with the sham operation (SO) group.
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drome, AP always triggers a hypercatabolic state, result-
ing in increased energy requirements and protein
catabolism [23]. Our results indicate that multiple meta-
bolic pathways were mobilized, resulting in changes in
metabolite concentrations. Lactate is mainly generated
by anaerobic glycolysis and is not associated with the
primary energy supply pathway under normal condi-
tions. During an intense workout or under conditions of
hypoxia, an insufficient oxygen supply can reduce Krebs
cycle reactions, produce less ATP, and enhance glycoly-
sis, resulting in decreased removal ability of the liver and
kidneys and ultimately to the accumulation of lactate in
plasma [24,25]. The increased levels of lactate and succi-
nic acid in the AP group were likely because of anaer-
obic glycolysis, which was enhanced by the increased
energy consumption and oxygen deficit during early
stages of AP [26]. Since lactate concentration is influ-
enced by oxygen supply and fluid resuscitation, this ele-
vation was not detected in urine samples from patients
with pancreatitis [27]. As an aerobic process, gluconeo-
genesis was inhibited by an inadequate oxygen supply,
which may be partly responsible for the decrease in glu-
cose level. Further, insulin released from injured acinar
cells also contributed to decreased glucose levels.
TMAO, the product of dietary choline and L-carnitine
[28] , although mainly regarded as a biomarker of renal
function [29], may participate in energy production as
an external electron acceptor in an hypoxic environ-
ment[30]. Moreover, decreased TMAO has been re-
ported to accompany a chemiosmotic mechanism of
energy conversion [31]. The decreased TMAO we ob-
served may indicate renal damage caused by AP as well
as energy conversion under conditions of relative oxygen
deficit. Similar changes in TMAO have been observed in
serum samples of patients with pancreatitis [32]. In con-
trast, 3-HB, a ketone body synthesized in the liver andused as an energy source by the brain under conditions of
hypoglycemia or enhanced demand for gluconeogenesis
[33], was not increased in serum samples of patients with
pancreatitis [32]. Inflammatory responses in AP progres-
sively damage pancreatic acinar cells and impair mito-
chondrial respiratory capacity, limiting ATP production
[34]. In addition, increased energy consumption mobilizes
FA to the periphery as an energy supply, reducing FA and
increasing 3-HB. This results in increased HDL level at
the periphery, where it is required to carry cholesterol and
triacylglycerol. Serum VLDL transports triacylglycerol into
tissue for energy metabolism, and phosphatidylcholine
moves into tissue to preserve cell function, leading to el-
evated serum HDL levels and decreased LDL, VLDL,
and phosphatidylcholine levels. UFA, which is important
in maintaining the relative liquidity of cell membranes
and normal cell function, is released into circulation under
stress, damaging the stability of cell membranes [35].
Moreover, glutaminate production is increased to protect
against tissue injury, and alanine accumulates to inhibit
the proteolysis of skeletal muscle proteins, resulting in in-
creased serum levels of glutaminate and alanine.
One of the limitations of this study was that we only
investigated changes in plasma concentrations of meta-
bolic factors. Further studies investigating urine and pan-
creatic tissue samples are needed to confirm our findings.
Moreover, insufficient plasma was available for assay of all
factors, and this study was based on the 1HNMR ap-
proach, which in itself is limited by the incomplete data
obtained. The combined use of LC-MS or GC-MS is
needed to validate our results.
Conclusion
We found that the characteristic metabolomic profile dif-
fered in AP and SO rats. Lactate, valine, succinic acid, 3-
HB, HDL, UFA, glycerol, choline, TMAO, glucose, glycine,
VLDL, and Ptd may be regarded as potential biomarkers of
early stage AP. These findings may provide deeper insight
into the pathophysiology and metabolic state of AP and
may facilitate early intervention in patients with this dis-
ease. The 1HNMR-based metabolomic approach was cap-
able of distinguishing between plasma samples of AP rats
and SO controls, providing a new and non-invasive meth-
odology for the study of AP.
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